No, although they are all blood-enriching drugs, there are still differences. The main component of Shengxuening tablets is sodium iron chlorophyllin, and its structure and physiological function are similar to human heme. Pharmacological research shows that Shengxuening tablet can not only effectively supplement iron, but also stimulate bone marrow hematopoiesis, so it is an ideal red blood cell activator. Clinical studies have proved that Shengxuening tablets have better curative effect than traditional iron agents, especially without the common side effects and adverse reactions of traditional iron agents. Absorption is not affected by dietary factors. Comparatively speaking, it is relatively better in terms of safety, absorption rate and curative effect.